Status:
NOT_YET_RECRUITING
ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery
Lead Sponsor:
University of California, San Francisco
Conditions:
Indocyanine Green
Skull Base Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Endonasal endoscopic approaches are an established treatment for suprasellar lesions compromising the optic nerves (ON). Surgery often involves dissecting tumors from the optic nerves and its blood su...
Eligibility Criteria
Inclusion
- The study will enroll adult (18 y.o. and older) participants undergoing endonasal endoscopic surgery for suprasellar tumors including meningiomas, craniopharyngiomas and pituitary adenomas.
Exclusion
- Underage patients (younger than 18 y.o).
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06501716
Start Date
July 1 2024
End Date
December 1 2025
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143